Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: May 2009
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Stiefel Laboratories Inc. v. KV Pharmaceutical Co.1:09-cv-00376; filed May 28, 2009 in the District Court of Delaware Infringement of U.S. Patent No.…
-
June 16-17, 2009 – Biotech Patenting (C5) – Munich, Germany June 19, 2009 – Patent Enforcement & Early Stage Litigation (Law Seminars International) – San Francisco, CA June 22-27, 2009 – Innovation Week 2009 (U.S. Patent and Trademark Office) – Arlington, VA June 21-23, 2009 – IP Business Congress (Intellectual Asset Management magazine) – Chicago,…
-
Practising Law Institute (PLI) will be holding a seminar entitled: "Prior Art & Obviousness 2009: The PTO & CAFC Perspective on Patent Law Sections 102 & 103" on July 6, 2009 in New York, NY and on September 1, 2009 in San Francisco, CA. The seminar will provide information on the following topics: • When…
-
Practising Law Institute (PLI) will be holding a seminar entitled: "Markman Hearings and Claim Construction in Patent Litigation" on July 8, 2009 in New York, NY. Groupcasts of the New York session will also be held in New Brunswick, NJ; Philadelphia, PA; and Pittsburgh, PA. The seminar will provide information on the following topics: •…
-
By Kevin E. Noonan — Last week, Biogen Idec sponsored a "Super Session" at the BIO 2009 International Conference entitled "Weathering the Perfect Storm of Financial Distress and Political Pressure." The session was moderated by Stephen Sands, Lazard Freres & Co., for a panel consisting of Broderick D. Johnson, Bryan Cave; Scott Gottlieb M.D.,…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office has posted on the top page of the EFS-Web portal site an advisory that the system will be unavailable because of system maintenance. According to the advisory, the maintenance is scheduled to begin at midnight and end at 4 a.m. on Sunday, May…
-
By Donald Zuhn — In a Breakout Session entitled "The Narrowing Scope of Biotech Patent Claims: What Does It Mean for the Industry?" at last week's BIO International Convention, a panel consisting of Anne Dollard, the Deputy General Counsel and Chief Patent Counsel for Takeda San Francisco; Thomas Kim, Senior Director of Intellectual Property…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Teva Pharmaceutical Industries Ltd. et al. v. Amgen Inc.2:09-cv-02256; filed May 20, 2009 in the Eastern District of Pennsylvania Infringement of U.S.…
-
By Kevin E. Noonan — Last week, Eli Lilly & Co. sponsored a "Super Session" at the BIO 2009 International Conference entitled "Biotechnology Intellectual Property at the Crossroads." The session was moderated by John Lechleiter, President and Chief Executive Officer at Lilly, for a panel consisting of Robert Armitage, Lilly's General Counsel; Gregory Glover…
-
By Sherri Oslick — In a Breakout Session held last Wednesday at BIO 2009, a panel consisting of David Bassett, a Partner at WilmerHale; Genia Long, Managing Principal at Analysis Group; David Ridley, Assistant Professor of Business Administration at the Fuqua School of Business at Duke University; David Korn, Sr. Assistant General Counsel for…
Patent Docs 